Taxoprexin® Treatment for Advanced Eye Melanoma

Summary

To evaluate objective response rate and duration of response to weekly Taxoprexin®. To evaluate the safety profile of weekly Taxoprexin® in this patient population. To evaluate overall survival in the same patient population. To evaluate time to disease progression, and the time to treatment failure in patients with metastatic choroidal melanoma being treated with weekly Taxoprexin® Injection.

Timeline

Start

2005-10

Primary completion

2008-06

Completion

2008-06

Drugs

Indications